BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3394756)

  • 1. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
    Rao GS; Hanjani P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
    Qian HN; Feng J; Fu TY
    Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.
    Giancotti FR; Dorsett BH; Qian HN; Cronin WJ; Barber HR; Ioachim HL
    Gynecol Oncol; 1990 Apr; 37(1):24-8. PubMed ID: 2182406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of tumor-specific antibodies from effusions of ovarian carcinomas.
    Dorsett BH; Ioachim HL; Stolbach L; Walker J; Barber HR
    Int J Cancer; 1975 Nov; 16(5):779-86. PubMed ID: 1184243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
    Kutteh WH; Doellgast GJ
    J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of tumour-associated immunoglobulins from ascitic fluid.
    Hill R; Daunter B; Khoo SK; MacKay EV
    Br J Cancer; 1978 Jul; 38(1):154-7. PubMed ID: 687514
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of tumor-associated immunoglobulin G isolated from immune complexes in ascitic fluid of ovarian cancer.
    Silburn PA; Khoo SK; Hill R; Daunter B; Mackay EV
    Diagn Immunol; 1984; 2(1):30-5. PubMed ID: 6209058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
    Kawata M; Sekiya S
    Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
    Harlozinska A; Bar JK; Richter R; Cislo M
    Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of carcinoembryonic antigen purified from malignant ascitic fluid of serous cystadenocarcinoma of the ovary.
    Hill R; Daunter B; Khoo SK; Mackay EV
    Mol Immunol; 1981 Jul; 18(7):647-53. PubMed ID: 7300840
    [No Abstract]   [Full Text] [Related]  

  • 13. Affinity chromatography separation of tumor associated antigens from ascitic fluid of ovarian cancer patients.
    Hill R; Daunter B; Silburn PA; Khoo SK; Mackay EV
    Gynecol Oncol; 1983 Jun; 15(3):428-33. PubMed ID: 6407908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
    Pattillo RA; Story MT; Ruckert AC
    Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients.
    Taylor DD; Homesley HD; Doellgast GJ
    Am J Reprod Immunol (1980); 1983; 3(1):7-11. PubMed ID: 6859379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 17. Types of immune complexes in the ascitic fluid of women with carcinoma of the ovary.
    Silburn PA; Khoo SK; Daunter B; Hill R; Roberts TK; Mackay EV
    Int Arch Allergy Appl Immunol; 1983; 71(3):219-23. PubMed ID: 6602096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of secretory component levels in cyst fluids, ascitic fluids, and sera from ovarian adenocarcinoma patients.
    Klein JL; Gall SA; Dawson JR
    J Natl Cancer Inst; 1978 Jul; 61(1):57-60. PubMed ID: 209204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.